Skip to content
C17C17C17

Drawing based on the description in the official product monograph. No photo yet.

“500 mg are White biconvex, film coated capsule shaped tablets, imprinted "C17" on one side contains 500 mg of cefprozil for administration by oral route”

C17 pill

Pill with imprint C17 is white, capsule and has been identified as Cefprozil 500 mg. It is used for bronchitis, sinus infections and ear infections. It is supplied by Auro Pharma Inc.

Sold in Canada

Cefprozil 500 mg

Brand
Auro-Cefprozil
Imprint
C17
Strength
500 mg
Used for
Bronchitis, sinus infections and ear infections
Color
White
Shape
Capsule / oblong
Form
Tablet
Manufacturer
Auro Pharma Inc
Drug class
Antibiotic (cephalosporin)
Sold in
Canada
DIN
02347253

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Cefprozil pills and guides

What is Cefprozil used for?

Cefprozil is used for bronchitis, sinus infections, ear infections and sore throat (including strep).

Medicine type
Antibiotic (cephalosporin)
Official uses from the US prescribing label

Cefprozil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below:

Upper Respiratory Tract:

Pharyngitis/Tonsillitis:

Caused by Streptococcus pyogenes.

NOTE: The usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. Cefprozil is generally effective in the eradication of Streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are not available at present.

Otitis Media:

Caused by Streptococcus pneumoniae, Haemophilus influenzae (including ß-lactamase-producing strains), and Moraxella (Branhamella) catarrhalis (including ß-lactamase-producing strains). (See CLINICAL STUDIES.)

NOTE: In the treatment of otitis media due to ß-lactamase producing organisms, cefprozil had bacteriologic eradication rates somewhat lower than those observed with a product containing a specific ß-lactamase inhibitor. In considering the use of cefprozil, lower overall eradication rates should be balanced against the susceptibility patterns of the common microbes in a given geographic area and the increased potential for toxicity with products containing ß-lactamase inhibitors.

Acute Sinusitis:

Caused by Streptococcus pneumoniae, Haemophilus influenzae (including ß-lactamase producing strains), and Moraxella (Branhamella) catarrhalis (including ß-lactamase-producing strains).

Lower Respiratory Tract:

Acute Bacterial Exacerbation of Chronic Bronchitis:

Caused by Streptococcus pneumoniae, Haemophilus influenzae (including ß-lactamase-producing strains), and Moraxella (Branhamella) catarrhalis (including ß-lactamase-producing strains).

Skin and Skin Structure:

Uncomplicated Skin and Skin-Structure Infections:

Caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes. Abscesses usually require surgical drainage.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefprozil tablets and other antibacterial drugs, cefprozil tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

From the FDA-approved label on DailyMed (published Nov 17, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows C17.
  • It is white, capsule.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Auro-Cefprozil by Auro Pharma Inc.

In Canada: prescription only.

Ingredients

Active: Cefprozil

Other pills with imprint C 17

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Cefprozil pills